These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11529973)

  • 1. Timing of quality of life (QoL) assessments as a source of error in oncological trials.
    Hakamies-Blomqvist L; Luoma ML; Sjöström J; Pluzanska A; Sjödin M; Mouridsen H; Østenstad B; Mjaaland I; Ottosson S; Bergh J; Malmström PO; Blomqvist C
    J Adv Nurs; 2001 Sep; 35(5):709-16. PubMed ID: 11529973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.
    Hakamies-Blomqvist L; Luoma M; Sjöström J; Pluzanska A; Sjödin M; Mouridsen H; Ostenstad B; Mjaaland I; Ottosson-Lönn S; Bergh J; Malmström P; Blomqvist C
    Eur J Cancer; 2000 Jul; 36(11):1411-7. PubMed ID: 10899655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
    Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.
    Schwentner L; Harbeck N; Singer S; Eichler M; Rack B; Forstbauer H; Wischnik A; Scholz C; Huober J; Friedl TW; Weissenbacher T; Härtl K; Kiechle M; Janni W; Fink V
    Breast; 2016 Jun; 27():69-77. PubMed ID: 27054751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
    Macquart-Moulin G; Viens P; Palangié T; Bouscary ML; Delozier T; Roché H; Janvier M; Fabbro M; Moatti JP
    J Clin Oncol; 2000 Feb; 18(4):754-64. PubMed ID: 10673516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer.
    Luoma ML; Hakamies-Blomqvist L; Sjöström J; Pluzanska A; Ottoson S; Mouridsen H; Bengtsson NO; Bergh J; Malmström P; Valvere V; Tennvall L; Blomqvist C
    Eur J Cancer; 2003 Jul; 39(10):1370-6. PubMed ID: 12826039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.
    Hinz A; Mehnert A; Dégi C; Reissmann DR; Schotte D; Schulte T
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26568527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles.
    Sultan A; Choudhary V; Parganiha A
    Chronobiol Int; 2017; 34(5):609-623. PubMed ID: 28276853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG).
    Curran D; Fossa S; Aaronson N; Kiebert G; Keuppens F; Hall R
    Eur J Cancer; 1997 Oct; 33(11):1809-14. PubMed ID: 9470838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical performance, toxicity, and quality of life as assessed by the physician and the patient.
    Luoma ML; Hakamies-Blomqvist L; Sjöström J; Mouridsen H; Pluzanska A; Malmström P; Bengtsson NO; Hultborn R; Ostenstaad B; Mjaaland I; Valvere V; Wist E; Baldursson G; Ahigren J; Blomqvist C
    Acta Oncol; 2002; 41(1):44-9. PubMed ID: 11990517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation study of a quality of life (QOL) questionnaire for use in Iran.
    Safaee A; Moghim Dehkordi B
    Asian Pac J Cancer Prev; 2007; 8(4):543-6. PubMed ID: 18260726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life of Croatian breast cancer patients receiving adjuvant treatment--comparison to long-term breast cancer survivors.
    Murgić J; Soldić Z; Vrljić D; Samija I; Kirac I; Bolanca A; Kusić Z
    Coll Antropol; 2012 Dec; 36(4):1335-41. PubMed ID: 23390830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Sectional Patient-Reported Outcome Measuring of Health-Related Quality of Life With Establishment of Cancer- and Treatment-Specific Functional and Symptom Scales in Patients With Penile Cancer.
    Draeger DL; Sievert KD; Hakenberg OW
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1215-e1220. PubMed ID: 30201215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Validity and reliability of the quality of life questionnaire (EORTC QLQ C30) and its breast cancer module (EORTC QLQ BR23)].
    Zawisza K; Tobiasz-Adamczyk B; Nowak W; Kulig J; Jedrys J
    Ginekol Pol; 2010 Apr; 81(4):262-7. PubMed ID: 20476597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy.
    Wedding U; Koch A; Röhrig B; Pientka L; Sauer H; Höffken K; Maurer I
    Acta Oncol; 2008; 47(1):56-62. PubMed ID: 18097778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.